Page last updated: 2024-08-18

pyrroles and l 750667

pyrroles has been researched along with l 750667 in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (18.18)18.2507
2000's7 (63.64)29.6817
2010's2 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Curtis, NR; Emms, F; Freedman, SB; Kulagowski, JJ; Leeson, PD; Marston, D; Marwood, R; Patel, S1
Chumpradit, S; Kung, HF; Kung, MP; Stevenson, DA; Sun, XM; Vessotskie, JM; Zhuang, ZP1
Benjamin, PS; Schetz, JA; Sibley, DR1
Al Tikriti, MS; Baldwin, RM; Eshima, L; Fujita, M; Innis, RB; Lu, L; Roe, D; Seibyl, JP; Staley, JK; Tamagnan, G; Thornback, J1
Pittman, QJ; Price, CJ1
Chapman, KL; Hutson, PH; Marston, D; Patel, S; Ragan, CI1
Chen, S; Floresca, CZ; Kortagere, S; Schetz, JA1
Anderson, SM; Pierce, RC; Schmidt, HD1
Hashimoto, K; Higashi, T; Matsushita, S; Nakano, K; Takagi, R; Tanaka, Y1
Kaneko, A; Kawano, M; Matsushita, S; Takagi, R1
Chang, SE; Hwang, JS; Jung, JM; Kim, SY; Lee, WJ1

Other Studies

11 other study(ies) available for pyrroles and l 750667

ArticleYear
Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.
    Molecular pharmacology, 1996, Volume: 50, Issue:6

    Topics: Animals; Cell Line; Dopamine Antagonists; Humans; Iodine Radioisotopes; Kinetics; Pyridines; Pyrroles; Radioligand Assay; Rats; Receptors, Dopamine D2; Receptors, Dopamine D4

1996
Characterization of a novel iodinated ligand, IPMPP, for human dopamine D4 receptors expressed in CHO cells.
    Life sciences, 1997, Volume: 60, Issue:2

    Topics: Animals; Binding, Competitive; CHO Cells; Cricetinae; Dopamine Agonists; Guanine Nucleotides; Humans; Magnesium; Pyridines; Pyrroles; Radioligand Assay; Receptors, Dopamine D2; Receptors, Dopamine D4; Recombinant Proteins

1997
Nonconserved residues in the second transmembrane-spanning domain of the D(4) dopamine receptor are molecular determinants of D(4)-selective pharmacology.
    Molecular pharmacology, 2000, Volume: 57, Issue:1

    Topics: Animals; Binding Sites; COS Cells; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ligands; Membrane Proteins; Mutagenesis, Site-Directed; Protein Conformation; Pyridines; Pyrroles; Rats; Receptors, Dopamine D2; Receptors, Dopamine D4; Structure-Activity Relationship; Transfection

2000
SPECT imaging with the D(4) receptor antagonist L-750,667 in nonhuman primate brain.
    Nuclear medicine and biology, 2000, Volume: 27, Issue:6

    Topics: Animals; Basal Ganglia; Binding, Competitive; Brain; Brain Stem; Cerebellum; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Frontal Lobe; Gyrus Cinguli; Imidazoles; Iodine Radioisotopes; Occipital Lobe; Organ Specificity; Papio; Parietal Lobe; Pyridines; Pyrimidines; Pyrroles; Receptors, Dopamine D4; Temporal Lobe; Tissue Distribution; Tomography, Emission-Computed, Single-Photon

2000
Dopamine D4 receptor activation inhibits presynaptically glutamatergic neurotransmission in the rat supraoptic nucleus.
    Journal of neurophysiology, 2001, Volume: 86, Issue:3

    Topics: Animals; Benzamides; Benzazepines; Clozapine; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Glutamic Acid; Male; Patch-Clamp Techniques; Piperazines; Presynaptic Terminals; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D4; Sulpiride; Supraoptic Nucleus; Synaptic Transmission

2001
Pharmacological and functional characterisation of dopamine D4 receptors in the rat retina.
    Neuropharmacology, 2003, Volume: 44, Issue:8

    Topics: Animals; Binding Sites; Cyclic AMP; Darkness; Dopamine Agonists; Dopamine Antagonists; In Vitro Techniques; Indoles; Male; Piperidines; Pyridines; Pyrroles; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D4; Retina; Spiperone

2003
Reciprocal mutations in TM2/TM3 in a D2 dopamine receptor background confirms the importance of this microdomain as a selective determinant of para-halogenated 1,4-disubstituted aromatic piperazines.
    Archiv der Pharmazie, 2005, Volume: 338, Issue:5-6

    Topics: Animals; Chemistry, Pharmaceutical; Chlorocebus aethiops; COS Cells; Membrane Microdomains; Membrane Transport Proteins; Mutation; Piperazine; Piperazines; Pyrazoles; Pyridines; Pyrroles; Rats; Receptors, Dopamine D2; Spiperone; Tritium

2005
Administration of the D2 dopamine receptor antagonist sulpiride into the shell, but not the core, of the nucleus accumbens attenuates cocaine priming-induced reinstatement of drug seeking.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:7

    Topics: Analysis of Variance; Animals; Behavior, Addictive; Behavior, Animal; Cocaine; Conditioning, Operant; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Extinction, Psychological; Indans; Male; Microinjections; Nucleus Accumbens; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Self Administration; Sulpiride

2006
Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis.
    Biochemical and biophysical research communications, 2008, Aug-22, Volume: 373, Issue:2

    Topics: Adoptive Transfer; Animals; Benzazepines; Cell Differentiation; Cell Polarity; Dendritic Cells; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Interleukin-17; Lymphocyte Activation; Mice; Pyridines; Pyrroles; Receptors, Dopamine D1; T-Lymphocytes, Helper-Inducer

2008
Berberine is a dopamine D1- and D2-like receptor antagonist and ameliorates experimentally induced colitis by suppressing innate and adaptive immune responses.
    Journal of neuroimmunology, 2015, Dec-15, Volume: 289

    Topics: Adaptive Immunity; Animals; Benzazepines; Berberine; Bone Marrow; Colitis; Cytokines; Dendritic Cells; Dextran Sulfate; Disease Models, Animal; Dopamine Antagonists; Immunity, Innate; Lipopolysaccharides; Lymph Nodes; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Protein Binding; Pyridines; Pyrroles; Receptors, Dopamine; Receptors, Serotonin; Time Factors

2015
Dopamine D4 receptor antagonist inhibits melanogenesis through transcriptional downregulation of MITF via ERK signalling.
    Experimental dermatology, 2016, Volume: 25, Issue:4

    Topics: Cell Survival; Dopamine; Dose-Response Relationship, Drug; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Humans; Melanins; Melanocytes; Microphthalmia-Associated Transcription Factor; Pyridines; Pyrroles; Receptors, Dopamine D4; RNA, Messenger; Signal Transduction

2016